{ "cik": 1430306, "cik_padded": "0001430306", "entityName": "Tonix Pharmaceuticals Holding Corp.", "fiscal_years": [ { "accn": "0001999371-26-005730", "filed": "2026-03-12", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 13760000.0, "capex": 3369000.0, "cash": 207637000.0, "eps_diluted": -14.57, "free_cash_flow": -103213000.0, "net_income": -124021000.0, "operating_cash_flow": -99844000.0, "operating_income": -125703000.0, "revenue": 13107000.0, "stockholders_equity": 245150000.0, "total_assets": 277171000.0, "total_liabilities": 32021000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1306179889863349, "revenue_growth_yoy": 0.2984941549435308, "roa_avg2y": -0.5636536752859262, "roa_period_end": -0.44745301636895635, "roe_avg2y": -0.6447539432504653, "roe_period_end": -0.5058984295329391 } }, { "accn": "0001999371-26-005730", "filed": "2026-03-12", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 120000.0, "cash": 98776000.0, "eps_diluted": -176.6, "free_cash_flow": -61045000.0, "net_income": -130036000.0, "operating_cash_flow": -60925000.0, "operating_income": -136701000.0, "revenue": 10094000.0, "stockholders_equity": 139558000.0, "total_assets": 162890000.0, "total_liabilities": 23332000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.16718496969002136, "revenue_growth_yoy": 0.2994335736354274, "roa_avg2y": -0.819519327423924, "roa_period_end": -0.7983056050095156, "roe_avg2y": -1.0611588727084293, "roe_period_end": -0.9317703033864057 } }, { "accn": "0001999371-26-005730", "filed": "2026-03-12", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 13965000.0, "capex": 7895000.0, "cash": 24948000.0, "eps_diluted": -14720.25, "free_cash_flow": -109898000.0, "net_income": -116658000.0, "operating_cash_flow": -102003000.0, "operating_income": -118380000.0, "revenue": 7768000.0, "stockholders_equity": 105525000.0, "total_assets": 154457000.0, "total_liabilities": 48932000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.46370054489457474, "roa_avg2y": -0.61375204854964, "roa_period_end": -0.7552781680338218, "roe_avg2y": -0.7461169721176693, "roe_period_end": -1.105501066098081 } }, { "accn": "0001999371-25-002786", "filed": "2025-03-18", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 48147000.0, "cash": 120229000.0, "eps_diluted": -20.01, "free_cash_flow": -146200000.0, "net_income": -110218000.0, "operating_cash_flow": -98053000.0, "operating_income": -112091000.0, "stockholders_equity": 207182000.0, "total_assets": 225690000.0, "total_liabilities": 18508000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08933208483362454, "roa_avg2y": -0.4724404723633168, "roa_period_end": -0.4883601400150649, "roe_avg2y": -0.5175781112423368, "roe_period_end": -0.5319863694722514 } }, { "accn": "0001999371-24-004297", "filed": "2024-04-01", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 35307000.0, "cash": 178660000.0, "eps_diluted": -8.1, "free_cash_flow": -110864000.0, "net_income": -92287000.0, "operating_cash_flow": -75557000.0, "operating_income": -92312000.0, "stockholders_equity": 218717000.0, "total_assets": 240900000.0, "total_liabilities": 22183000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1014233004293219, "roa_avg2y": -0.544332803472896, "roa_period_end": -0.38309256953092574, "roe_avg2y": -0.602464380722341, "roe_period_end": -0.42194708230270167 } }, { "accn": "0001387131-23-003377", "filed": "2023-03-13", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 8564000.0, "cash": 77068000.0, "free_cash_flow": -57130000.0, "net_income": -50463000.0, "operating_cash_flow": -48566000.0, "operating_income": -50511000.0, "stockholders_equity": 87648000.0, "total_assets": 98183000.0, "total_liabilities": 10535000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.12019669587440672, "roa_avg2y": -0.8952022777871405, "roa_period_end": -0.513968813338358, "roe_avg2y": -1.0397774687065369, "roe_period_end": -0.5757461664841182 } }, { "accn": "0001387131-22-003640", "filed": "2022-03-14", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 17000.0, "cash": 11249000.0, "free_cash_flow": -26700000.0, "net_income": -28618000.0, "operating_cash_flow": -26683000.0, "operating_income": -28828000.0, "stockholders_equity": 9417000.0, "total_assets": 14558000.0, "total_liabilities": 5141000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5459275777848571, "roa_avg2y": -1.4002006018054163, "roa_period_end": -1.9657920043962083, "roe_avg2y": -1.7301774432453674, "roe_period_end": -3.0389720717850697 } }, { "accn": "0001387131-21-003550", "filed": "2021-03-15", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6000.0, "cash": 25034000.0, "free_cash_flow": -23977000.0, "net_income": -26089000.0, "operating_cash_flow": -23971000.0, "operating_income": -26322000.0, "stockholders_equity": 23664000.0, "total_assets": 26319000.0, "total_liabilities": 2655000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.11219574036511157, "roa_avg2y": -0.9831364347219868, "roa_period_end": -0.9912610661499298, "roe_avg2y": -1.0807373653686827, "roe_period_end": -1.1024763353617308 } }, { "accn": "0001387131-20-003189", "filed": "2020-03-24", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5000.0, "cash": 25496000.0, "free_cash_flow": -19133000.0, "net_income": -21123000.0, "operating_cash_flow": -19128000.0, "operating_income": -21291000.0, "stockholders_equity": 24616000.0, "total_assets": 26754000.0, "total_liabilities": 2138000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.0868540786480338, "roa_avg2y": -0.7785272003538257, "roa_period_end": -0.7895267997308814, "roe_avg2y": -0.845308842067351, "roe_period_end": -0.8581004224894377 } }, { "accn": "0001615774-18-001762", "filed": "2019-03-18", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 66000.0, "cash": 18941000.0, "free_cash_flow": -37379000.0, "net_income": -38842000.0, "operating_cash_flow": -37313000.0, "operating_income": -38969000.0, "stockholders_equity": 25361000.0, "total_assets": 27510000.0, "total_liabilities": 2149000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08473640629312724, "roa_period_end": -1.4119229371137765, "roe_period_end": -1.5315642127676354 } } ], "latest_filing": { "accn": "0001999371-26-005730", "filed": "2026-03-12", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001430306.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001430306.json" }, "ticker": "TNXP" }